Correction: Extended-release amphetamine (Dyanavel XR) is associated with reduced immediate-release supplementation in adults with ADHD, regardless of baseline patient variables: a retrospective cohort analysis of medical treatment records.

IF 3.4 2区医学 Q2 PSYCHIATRY

BMC Psychiatry Pub Date : 2025-06-05 DOI:10.1186/s12888-025-06903-3

Joel L Young, Richard N Powell, Anna Powell, Lisa L M Welling, Lauren Granata, Jaime Saal, Margot Nash

引用次数: 0

查看原文本刊更多论文

更正：缓释安非他明（Dyanavel XR）与ADHD成人患者立即释放补充减少相关，无论基线患者变量：医疗记录的回顾性队列分析。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Psychiatry 医学-精神病学

CiteScore

5.90

自引率

4.50%

发文量

716

审稿时长

3-6 weeks

期刊介绍： BMC Psychiatry is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of psychiatric disorders, as well as related molecular genetics, pathophysiology, and epidemiology.